← Back to NASA Technology Projects
Completed TRL 7 (started at 3, targeting 7)
The technology will also enable operational and research applications (LUNAR PARTICULATE RESEARCH), and potential terrestrial spin off benefits for military, third world medicine, outbreaks.
The physiological dysregulations observed on ISS is likely to worsen on the lunar surface. The proposed novel technology will provide needed diagnostic capability on the lunar surface to surgeons to assist diagnosis of certain illnesses and selection of treatment options.
Listed on TechPort itself — the most direct way to ask about this specific project.
This is a mature technology (TRL 7) — the realistic path in is usually NASA's Technology Transfer Program: licensing an existing NASA patent, or a Space Act Agreement to use NASA facilities/expertise directly. NASA also runs a startup licensing program with no upfront fee for companies formed to commercialize a specific NASA technology.
None of these are guaranteed paths for this specific project — TechPort itself doesn't have an "apply" button. Reaching out to the contact(s) above with a specific question is usually the fastest way to find out what's actually open.